Trial · NCT01570985
Treatment Study of Frozen Shoulder: Corticosteroid Injection in Joint Versus Wait and See Policy
NCT01570985, Phase 3, Unknown, Satya Pal Sharma
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Treatment Study of Frozen Shoulder: Corticosteroid Injection in Joint Versus Wait and See Policy. Trials, record NCT01570985. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT01570985
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Treatment Study of Frozen Shoulder: Corticosteroid Injection in Joint Versus Wait and See Policy
- NCT number
- NCT01570985
- Status
- Unknown
- Phases
- Phase 3
- Enrollment
- 120 participants, estimated
- Lead sponsor
- Satya Pal Sharma
- Conditions
- Shoulder Capsulitis, Shoulder Adhesive Capsulitis, Frozen Shoulder
- Interventions
- Triamcinolone Acetonide, Triamcinolone Acetonide
- First posted
- 2012-04-04
- Last updated
- 2015-05-28
- Other registries' IDs
- eudract:2008-004385-49
Source ClinicalTrials.gov
Registered outcomes2
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Shoulder pain and disability index (SPADI) | 8 weeks | The primary outcome measure is Shoulder Pain and Disability Index (SPADI). According to a previous study, the SPADI score of ≥10 indicate clinically important improvement (or worsening) of shoulder function (Williams et al. 1995). A total of 3 measurements will be taken for all participants: baseline measurement on day 1, 2nd measurement on the 31st day and last measurement the 61st day. All end point effect measurements (primary, secondary \& tertiary) are targeted at 61 days.In addition pain and function (SPADI) will be evaluated at 6 months and 12 months. |
| Secondary | A 10-point Numerical Pain Rating Scale (NPRS) | 8 weeks | A total of 3 measurements will be taken for all participants: baseline measurement on day 1, 2nd measurement on the 31st day and last measurement the 61st day. All end point effect measurements (primary, secondary \& tertiary) are targeted at 61 days. |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers2
The papers the trial lists on ClinicalTrials.gov.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT01570985
GET https://conductscience.org/api/trials/v1/NCT01570985/registered